AFP and hepatocellular carcinoma: Regarding the suggested guidelines for HCC surveillance, whether tumor markers should be included in a surveillance program, along with ultrasonography, remains controversial, since the sensitivity or specificity of alpha-fetoprotein (AFP), which has been the most widely used tumor marker for HCC, by itself is unsatisfactory10–13.